A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
Clinical trial NCT04503278 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04503278
- Sponsor
- BioNTech Cell & Gene Therapies GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2028-08-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.